V\u017edy\u0165 tyto p\u0159\u00edjmy ve v\u00fd\u0161i 19 miliard eur p\u0159inesly v p\u0159edchoz\u00edm finan\u010dn\u00edm roce zisk ve v\u00fd\u0161i 10 miliard eur. Nen\u00ed divu, proto\u017ee EU a \u0159ada st\u00e1t\u016f nejen hromadn\u011b objedn\u00e1vala, ale tak\u00e9 \u010d\u00e1ste\u010dn\u011b hradila n\u00e1klady na v\u00fdvoj, v\u00fdrobu a logistiku.<\/p>\n\n\n\n

V dal\u0161\u00edm bod\u011b je jasn\u011b p\u0159edstavena situace v oblasti ud\u011blov\u00e1n\u00ed licenc\u00ed a bezpe\u010dnosti, co\u017e je zcela v rozporu s t\u00edm, co neust\u00e1le tvrd\u00ed politici, \u00fa\u0159ady a m\u00e9dia:<\/p>\n\n\n\n

\"Je mo\u017en\u00e9, \u017ee nebudeme schopni prok\u00e1zat dostate\u010dnou \u00fa\u010dinnost nebo bezpe\u010dnost na\u0161\u00ed vakc\u00edny COVID-19 a\/nebo specifick\u00fdch variant vakc\u00edny, abychom z\u00edskali trval\u00e9 schv\u00e1len\u00ed regula\u010dn\u00edmi org\u00e1ny ve Spojen\u00fdch st\u00e1tech, Velk\u00e9 Brit\u00e1nii, Evropsk\u00e9 unii nebo jin\u00fdch zem\u00edch, kde byla vakc\u00edna schv\u00e1lena pro nouzov\u00e9 pou\u017eit\u00ed nebo kde j\u00ed bylo ud\u011bleno podm\u00edn\u011bn\u00e9 schv\u00e1len\u00ed k uveden\u00ed na trh.\"<\/code><\/pre>\n\n\n\n
Vedlej\u0161\u00ed \u00fa\u010dinky jsou v\u0161ak tak\u00e9 prezentov\u00e1ny zcela jin\u00fdm zp\u016fsobem, ne\u017e jak to d\u011blaj\u00ed zdravotnick\u00e9 org\u00e1ny a zejm\u00e9na r\u016fzn\u00e9 o\u010dkovac\u00ed komise a poradn\u00ed org\u00e1ny:<\/p>\n\n\n\n
\"V pr\u016fb\u011bhu klinick\u00fdch zkou\u0161ek nebo i po jejich schv\u00e1len\u00ed regula\u010dn\u00edmi org\u00e1ny m\u016f\u017ee doj\u00edt k z\u00e1va\u017en\u00fdm ne\u017e\u00e1douc\u00edm ud\u00e1lostem, kter\u00e9 mohou zpozdit nebo ukon\u010dit klinick\u00e9 zkou\u0161ky a zpozdit nebo zabr\u00e1nit schv\u00e1len\u00ed regula\u010dn\u00edmi org\u00e1ny nebo p\u0159ijet\u00ed na\u0161ich kandid\u00e1t\u016f na produkty na trh.\"<\/code><\/pre>\n\n\n\n
Spole\u010dnost BioNTech zcela jasn\u011b uv\u00e1d\u00ed, \u017ee vakc\u00edna je schopna poskytnout pouze kr\u00e1tkodobou ochranu, a ani pro to, v rozporu s tvrzen\u00edm \u00fa\u0159ad\u016f a m\u00e9di\u00ed, zat\u00edm neexistuj\u00ed \u017e\u00e1dn\u00e9 d\u016fkazy v klinick\u00fdch studi\u00edch. Z\u00e1va\u017en\u00e9 a \u010dast\u00e9 ne\u017e\u00e1douc\u00ed \u00fa\u010dinky jsou rovn\u011b\u017e dob\u0159e zn\u00e1my, stejn\u011b jako skute\u010dnost, \u017ee tyto nebyly zaznamen\u00e1ny v registra\u010dn\u00ed studii, ale byly odstran\u011bny:<\/p>\n\n\n\n
\"Na\u0161e budouc\u00ed p\u0159\u00edjmy z prodeje vakc\u00edny COVID-19 z\u00e1vis\u00ed na mnoha faktorech, v\u010detn\u011b: (...) trvanlivost imunitn\u00ed odpov\u011bdi vyvolan\u00e9 na\u0161\u00ed vakc\u00ednou, kter\u00e1 dosud nebyla prok\u00e1z\u00e1na v klinick\u00fdch studi\u00edch (...), bezpe\u010dnostn\u00ed profil na\u0161\u00ed vakc\u00edny, v\u010detn\u011b toho, zda se u na\u0161\u00ed vakc\u00edny objev\u00ed n\u011bjak\u00e9 dosud nezn\u00e1m\u00e9 ne\u017e\u00e1douc\u00ed \u00fa\u010dinky nebo zv\u00fd\u0161en\u00fd v\u00fdskyt \u010di z\u00e1va\u017enost zn\u00e1m\u00fdch ne\u017e\u00e1douc\u00edch \u00fa\u010dink\u016f ve srovn\u00e1n\u00ed s t\u011bmi, kter\u00e9 byly pozorov\u00e1ny b\u011bhem klinick\u00e9ho hodnocen\u00ed.\"<\/code><\/pre>\n\n\n\n
Obecn\u011b je ot\u00e1zkou, jak se bude Corona vyv\u00edjet d\u00e1l, rozhodn\u011b hroz\u00ed, \u017ee v populaci p\u0159evl\u00e1dne v\u011bdom\u00ed, \u017ee s infekc\u00ed se mezit\u00edm nestane nic v\u00edc ne\u017e nachlazen\u00ed, a proto by politici a \u00fa\u0159ady mohli b\u00fdt nuceni opat\u0159en\u00ed tak\u00e9 zru\u0161it. A proto zpr\u00e1va zpochyb\u0148uje, do jak\u00e9 m\u00edry je vakc\u00edna “nezbytn\u00e1 i po skon\u010den\u00ed sou\u010dasn\u00e9 pandemie, pokud se jedn\u00e1 o endemick\u00fd virus”. Dokonce se pt\u00e1, dod\u00e1v\u00e1,<\/p>\n\n\n\n
\"trvanlivost imunitn\u00ed odpov\u011bdi vyvolan\u00e9 na\u0161\u00ed vakc\u00ednou COVID-19, kter\u00e1 dosud nebyla prok\u00e1z\u00e1na v klinick\u00fdch studi\u00edch\".<\/code><\/pre>\n\n\n\n
Se\u010dteno a podtr\u017eeno, BioNTech tak potvrzuje, \u017ee o\u010dkovac\u00ed sch\u00e9ma s dvoj\u00edm “z\u00e1kladn\u00edm o\u010dkov\u00e1n\u00edm”, posilovac\u00ed vakc\u00ednou a posilovac\u00ed vakc\u00ednou postr\u00e1dalo jak\u00fdkoli v\u011bdeck\u00fd z\u00e1klad, a to navzdory tvrzen\u00ed st\u00e1tn\u00edch org\u00e1n\u016f, EU, EMA, Gecka, N\u00e1rodn\u00edho o\u010dkovac\u00edho panelu a STIKO, AGES a RKI, PEI a BASG a p\u0159\u00edslu\u0161n\u00fdch ministr\u016f.<\/p>\n\n\n\n
Ani s \u00fa\u010detnictv\u00edm to v BioNTechu nevypad\u00e1 dob\u0159e:<\/p>\n\n\n\n
\"V minulosti jsme zjistili v\u00fdznamn\u00e9 nedostatky v na\u0161\u00ed vnit\u0159n\u00ed kontrole finan\u010dn\u00edho v\u00fdkaznictv\u00ed a v budoucnu m\u016f\u017eeme zjistit dal\u0161\u00ed v\u00fdznamn\u00e9 nedostatky, kter\u00e9 by mohly zp\u016fsobit, \u017ee nespln\u00edme na\u0161e povinnosti v oblasti v\u00fdkaznictv\u00ed nebo \u017ee se v na\u0161\u00ed \u00fa\u010detn\u00ed z\u00e1v\u011brce objev\u00ed v\u00fdznamn\u00e9 nespr\u00e1vnosti. Pokud se n\u00e1m nepoda\u0159\u00ed odstranit na\u0161e v\u00fdznamn\u00e9 nedostatky, je mo\u017en\u00e9, \u017ee nebudeme schopni p\u0159esn\u011b vyk\u00e1zat na\u0161e finan\u010dn\u00ed v\u00fdsledky nebo zabr\u00e1nit podvod\u016fm.\"<\/code><\/pre>\n\n\n\n
Obava z odpov\u011bdnosti a zpo\u017ed\u011bn\u00e9 n\u00e1hrady \u0161kody<\/p>\n\n\n\n
Spole\u010dnost BioNTech podle n\u011bj “nem\u016f\u017ee zaru\u010dit, \u017ee se nov\u011b objeven\u00e9 nebo vyvinut\u00e9 bezpe\u010dnostn\u00ed probl\u00e9my nevyskytnou”. A ve velmi pozoruhodn\u00e9m rozporu s argumentem, kter\u00fd \u010dasto uv\u00e1d\u011bj\u00ed r\u016fzn\u00ed “odborn\u00edci”, \u017ee nem\u016f\u017ee doj\u00edt k \u017e\u00e1dn\u00fdm dlouhodob\u00fdm n\u00e1sledk\u016fm, proto\u017ee vedlej\u0161\u00ed \u00fa\u010dinky se v\u017edy projev\u00ed okam\u017eit\u011b, pak BioNTech ve zpr\u00e1v\u011b uv\u00e1d\u00ed:<\/p>\n\n\n\n
\"Pokud je vakc\u00edna pou\u017e\u00edv\u00e1na \u0161irokou populac\u00ed pacient\u016f, mohou se \u010das od \u010dasu vyskytnout z\u00e1va\u017en\u00e9 ne\u017e\u00e1douc\u00ed \u00fa\u010dinky, kter\u00e9 se v klinick\u00fdch studi\u00edch p\u0159\u00edpravku nevyskytly nebo kter\u00e9 se zpo\u010d\u00e1tku nezd\u00e1ly souviset s vakc\u00ednou samotnou a byly zji\u0161t\u011bny a\u017e na z\u00e1klad\u011b n\u00e1sledn\u00fdch informac\u00ed.\"<\/code><\/pre>\n\n\n\n
To by podle skupiny mohlo v\u00e9st k pozastaven\u00ed v\u00fdroby a uv\u00e1d\u011bn\u00ed na trh, ale tak\u00e9 ke “zna\u010dn\u00fdm n\u00e1rok\u016fm na n\u00e1hradu \u0161kody”. Na toto tvrzen\u00ed skupina doslova navazuje:<\/p>\n\n\n\n
\"N\u00e1sledn\u00e9 odhalen\u00ed d\u0159\u00edve nezji\u0161t\u011bn\u00fdch probl\u00e9m\u016f by mohlo nep\u0159\u00edzniv\u011b ovlivnit komer\u010dn\u00ed prodej v\u00fdrobku, v\u00e9st k omezen\u00ed v\u00fdrobku nebo k jeho sta\u017een\u00ed z trhu.\"<\/code><\/pre>\n\n\n\n
Pointa je v tom, \u017ee zpr\u00e1va o akci\u00edch spole\u010dnosti BioNTech \u0159\u00edk\u00e1 prav\u00fd opak toho, co n\u00e1m p\u0159\u00edslu\u0161n\u00e9 org\u00e1ny a m\u00e9dia den co den serv\u00edruj\u00ed jako propagandu.<\/p>\n\n\n\n
Jak jsme vid\u011bli, burzovn\u00ed zpr\u00e1vy \u017eivotn\u00edch poji\u0161\u0165oven a poh\u0159ebn\u00edch \u00fastav\u016f na konci roku 2021 tato rizika jasn\u011b odhalily. \u017divotn\u00ed poji\u0161\u0165ovny zv\u00fd\u0161ily v\u00fdplaty a\u017e o 60 % jen v segmentu profesion\u00e1l\u016f mezi 18 a 65 lety, co\u017e bylo p\u0159i\u010d\u00edt\u00e1no \u00famrt\u00edm v d\u016fsledku o\u010dkov\u00e1n\u00ed. Ze stejn\u00e9ho d\u016fvodu vzrostl po\u010det podnikatel\u016f o 40 %. Pokud spole\u010dnost BioNTech tato rizika zataj\u00ed, hroz\u00ed j\u00ed odpov\u011bdnost a n\u00e1roky na n\u00e1hradu \u0161kody ve v\u00fd\u0161i, kter\u00e1 je pro ni likvida\u010dn\u00ed, a tak\u00e9 trestn\u011bpr\u00e1vn\u00ed d\u016fsledky. V\u00fd\u0161e popsan\u00e1 rizika \u00famrt\u00ed a z\u00e1va\u017en\u00fdch ne\u017e\u00e1douc\u00edch \u00fa\u010dink\u016f lze velmi dob\u0159e odhalit z burzovn\u00edch zpr\u00e1v jin\u00fdch spole\u010dnost\u00ed.<\/p>\n\n\n\n
<\/p>\n","protected":false},"excerpt":{"rendered":"
Politici a m\u00e9dia neochv\u011bjn\u011b tvrd\u00ed, \u017ee p\u0159\u00edpravky genov\u00e9ho in\u017een\u00fdrstv\u00ed, kter\u00e9 se u n\u00e1s o\u010dkuj\u00ed, jsou “bezpe\u010dn\u00e9 a \u00fa\u010dinn\u00e9”, dokonce “bez vedlej\u0161\u00edch \u00fa\u010dink\u016f”. 133 poslanc\u016f, kte\u0159\u00ed v Rakousku schv\u00e1lili z\u00e1kon o povinn\u00e9m o\u010dkov\u00e1n\u00ed, se myln\u011b domn\u00edvalo, \u017ee vakc\u00edny ji\u017e maj\u00ed \u0159\u00e1dnou licenci. Stejn\u011b jako v jin\u00fdch p\u0159\u00edpadech v\u0161ak \u00fa\u0159ady a zpr\u00e1vy spole\u010dnost\u00ed ukazuj\u00ed n\u011bco jin\u00e9ho. Nyn\u00ed tak\u00e9 zpr\u00e1va spole\u010dnosti BioNTech pro americkou Komisi pro cenn\u00e9 pap\u00edry.<\/p>\n","protected":false},"author":4,"featured_media":1251,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_expiration-date-status":"","_expiration-date":1650869670,"_expiration-date-type":"draft","_expiration-date-categories":[],"_expiration-date-options":[]},"categories":[3,462,5,6],"tags":[611,467,532,367,498,612,478],"class_list":["post-1250","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-eu","category-medicina","category-svet","category-usa","tag-biontech","tag-kovid","tag-mrna","tag-ockovani","tag-sars-cov-2","tag-tkp-at","tag-zdravi"],"_links":{"self":[{"href":"http:\/\/pohled.podhrazsky.eu\/subdom\/pohled\/wp-json\/wp\/v2\/posts\/1250","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/pohled.podhrazsky.eu\/subdom\/pohled\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/pohled.podhrazsky.eu\/subdom\/pohled\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/pohled.podhrazsky.eu\/subdom\/pohled\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"http:\/\/pohled.podhrazsky.eu\/subdom\/pohled\/wp-json\/wp\/v2\/comments?post=1250"}],"version-history":[{"count":1,"href":"http:\/\/pohled.podhrazsky.eu\/subdom\/pohled\/wp-json\/wp\/v2\/posts\/1250\/revisions"}],"predecessor-version":[{"id":1252,"href":"http:\/\/pohled.podhrazsky.eu\/subdom\/pohled\/wp-json\/wp\/v2\/posts\/1250\/revisions\/1252"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/pohled.podhrazsky.eu\/subdom\/pohled\/wp-json\/wp\/v2\/media\/1251"}],"wp:attachment":[{"href":"http:\/\/pohled.podhrazsky.eu\/subdom\/pohled\/wp-json\/wp\/v2\/media?parent=1250"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/pohled.podhrazsky.eu\/subdom\/pohled\/wp-json\/wp\/v2\/categories?post=1250"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/pohled.podhrazsky.eu\/subdom\/pohled\/wp-json\/wp\/v2\/tags?post=1250"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}